Latest News and Press Releases

NEW CANAAN, CT--(Marketwire - September 22, 2009) - Marshall Edwards, Inc. (NASDAQ: MSHL), a specialist oncology company focusing on the clinical development of novel anti-cancer therapeutics, today...

DALLAS, TX--(Marketwire - August 17, 2009) - HemoBioTech, Inc. (OTCBB: HMBT) has been working with a coalition of small biotechnology firms to implement legislation that will strengthen the Federal...

WASHINGTON, DC and SAN DIEGO, CA--(Marketwire - August 12, 2009) - WHITECOAT Strategies, a public relations firm specializing in the use of new media and online video for clients with innovative...

WASHINGTON, DC--(Marketwire - August 10, 2009) - Biota Holdings Limited (ASX: BTA) today announced successful results from the Asian Phase III clinical trials of CS-8958, its second generation...

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - August 5, 2009) - Novogen Limited (ASX: NRT) (NASDAQ: NVGN) and Marshall Edwards, Inc. (NASDAQ: MSHL) have concluded a license agreement for...

SYDNEY, AUSTRALIA--(Marketwire - July 30, 2009) - The Board of Novogen Limited (ASX: NRT) (NASDAQ: NVGN) has received and accepted the resignation of Mr. Peter B. Simpson as a Director of the...

NEW CANAAN, CT and SYDNEY, AUSTRALIA--(Marketwire - July 7, 2009) - Researchers at the Malaghan Institute of Medical Research in Wellington, New Zealand have found that abnormally proliferating human...

NEW CANAAN, CT--(Marketwire - June 17, 2009) - The Independent Data Monitoring Committee (IDMC) created to oversee the conduct of the Phase III OVArian TUmor REsponse (OVATURE) Trial, which convened...

DALLAS, TX--(Marketwire - June 2, 2009) - Representatives from HemoBioTech, Inc. (OTCBB: HMBT) will present "Developing blood substitutes for the prevention of HIV transmission," at the 5th...

WASHINGTON, DC--(Marketwire - May 12, 2009) - Amidst measures being taken to address the swine flu (H1N1 virus) outbreak, Operation USA and other groups are distributing precautionary kits that...